309 related articles for article (PubMed ID: 16278146)
41. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
[TBL] [Abstract][Full Text] [Related]
42. [Endothelial antibodies in Sneddon's syndrome].
Kalashnikova LA; Salozhin KV; Nasonov EL; Kosheleva NM; Reshetniak TM; Stoianovich LZ
Ter Arkh; 1996; 68(1):54-6. PubMed ID: 8644034
[TBL] [Abstract][Full Text] [Related]
43. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
44. Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures.
Taipa R; Santos E
Lupus; 2011 Nov; 20(13):1433-5. PubMed ID: 21768180
[TBL] [Abstract][Full Text] [Related]
45. Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.
Katopodis AG; Warner RG; Duthaler RO; Streiff MB; Bruelisauer A; Kretz O; Dorobek B; Persohn E; Andres H; Schweitzer A; Thoma G; Kinzy W; Quesniaux VF; Cozzi E; Davies HF; Mañez R; White D
J Clin Invest; 2002 Dec; 110(12):1869-77. PubMed ID: 12488437
[TBL] [Abstract][Full Text] [Related]
46. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
47. Autoimmune thrombocytopenia in two patients with Sneddon's Syndrome.
Meyer O; Worm M; Kiesewetter H; Salama A
Thromb Haemost; 2007 Dec; 98(6):1368-70. PubMed ID: 18064338
[No Abstract] [Full Text] [Related]
48. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
49. Sneddon's syndrome with bilateral peripheral retinal neovascularization.
Gobert A
Bull Soc Belge Ophtalmol; 1995; 255():85-90. PubMed ID: 7496580
[TBL] [Abstract][Full Text] [Related]
50. Cerebral manifestations in the antiphospholipid (Hughes) syndrome.
Sanna G; D'Cruz D; Cuadrado MJ
Rheum Dis Clin North Am; 2006 Aug; 32(3):465-90. PubMed ID: 16880079
[TBL] [Abstract][Full Text] [Related]
51. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
[TBL] [Abstract][Full Text] [Related]
52. LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor.
Koustova E; Sei Y; Fossom L; Wei ML; Usherwood PN; Keele NB; Rogawski MA; Basile AS
J Clin Invest; 2001 Mar; 107(6):737-44. PubMed ID: 11254673
[TBL] [Abstract][Full Text] [Related]
53. Anti-phospholipid antibodies and vascular pathology.
Derksen RH; de Groot PG; Kater L
Neth J Med; 1994 Dec; 45(6):257-61. PubMed ID: 7838241
[TBL] [Abstract][Full Text] [Related]
54. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?].
Kisiel E; Kryczka W
Przegl Lek; 2007; 64(7-8):521-4. PubMed ID: 18409357
[TBL] [Abstract][Full Text] [Related]
55. Cardiac manifestations in antiphospholipid syndrome.
Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
[TBL] [Abstract][Full Text] [Related]
56. Complement activation in patients with primary antiphospholipid syndrome.
Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
[TBL] [Abstract][Full Text] [Related]
57. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
Watson R; Jiang Y; Bermudez I; Houlihan L; Clover L; McKnight K; Cross JH; Hart IK; Roubertie A; Valmier J; Hart Y; Palace J; Beeson D; Vincent A; Lang B
Neurology; 2004 Jul; 63(1):43-50. PubMed ID: 15249609
[TBL] [Abstract][Full Text] [Related]
58. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
[TBL] [Abstract][Full Text] [Related]
59. [Sneddon's syndrome and the primary antiphospholipid syndrome].
Kalashnikova LA; Nasonov EL; Stoianovich LZ; Kovalev VIu; Kosheleva NM; Reshetniak TM
Ter Arkh; 1993; 65(3):64-70. PubMed ID: 8059389
[TBL] [Abstract][Full Text] [Related]
60. Classification of Sneddon's syndrome.
Schellong SM; Weissenborn K; Niedermeyer J; Wollenhaupt J; Sosada M; Ehrenheim C; Lubach D
Vasa; 1997 Aug; 26(3):215-21. PubMed ID: 9286155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
